SEC filing · 8-K

Pyxis Oncology, Inc.: Material agreement

Pyxis Oncology closed an underwritten public offering raising approximately $102.8 million in net proceeds.

Filed October 1, 2026

Positive for the company

What happened

The company sold 36,047,919 common shares and pre-funded warrants for 1,883,121 shares, accompanied by common warrants for up to 49,310,352 shares.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Pyxis Oncology, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.